4.7 Article

Prognostic significance of intra-tumoral budding in high-grade serous ovarian carcinomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pathology

Characterization ofTP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma

M. Herman Chui et al.

Summary: This study retrospectively reviewed 25 TP53-wildtype tubo-ovarian HGSCs and found that they share similar characteristics in morphology, genetic alterations, and pathological features with typical HGSC, despite lacking TP53 mutations.

MODERN PATHOLOGY (2021)

Review Oncology

Tumour budding in solid cancers

Alessandro Lugli et al.

Summary: Tumour budding serves as an emerging prognostic biomarker in colorectal cancer and other solid cancers, with its predictive accuracy being widely supported by evidence. The standardized scoring system agreed upon at the International Tumour Budding Consensus Conference allows for an independent prediction of pathological features and unfavorable survival outcomes in patients.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Oncology

Low-grade serous ovarian cancer: State of the science

Brian Slomovitz et al.

GYNECOLOGIC ONCOLOGY (2020)

Editorial Material Cell Biology

EMT and Cancer: More Than Meets the Eye

Rik Derynck et al.

DEVELOPMENTAL CELL (2019)

Article Medical Laboratory Technology

Tumor Budding in Colorectal Carcinoma Translating a Morphologic Score Into Clinically Meaningful Results

Soo-Jin Cho et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)

Review Pathology

The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded

Robert J. Kurman et al.

AMERICAN JOURNAL OF PATHOLOGY (2016)

Article Obstetrics & Gynecology

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing

Martin Kobel et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)

Article Multidisciplinary Sciences

High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence Risk

Bangxing Huang et al.

PLOS ONE (2016)

Article Pathology

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma

Martin Kobel et al.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)

Article Multidisciplinary Sciences

Integrated genomic analyses of ovarian carcinoma

D. Bell et al.

NATURE (2011)

Article Oncology

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

Richard W. Tothill et al.

CLINICAL CANCER RESEARCH (2008)

Article Pathology

Grading ovarian serous carcinoma using a two-tier system

A Malpica et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)